Business

Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2025 Restricted Stock Incentive Plan

Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2025 Restricted Stock Incentive Plan

articleShanghai Medicilon, Inc. Class ASeptember 8, 20254/news/publicity-explanation-and-verification-opinions-of-the-remuneration-and-appraisal-committee-of-the-board-of-directors-on-list-of-initially-granted-incentive-objects-in-the-2025-restricted-stock-incentive-plan-5
Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2025 Restricted Stock Incentive Plan

About this update from Shanghai Medicilon, Inc. Class A

Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2025 Restricted Stock Incentive PlanThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Medicilon, Inc. Class A